Editorial : anti-TNF therapy-a double-edged sword? Authors' reply
| Errataetall: |
CommentOn: Aliment Pharmacol Ther. 2019 Aug;50(3):289-294. - PMID 31267570 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Alimentary pharmacology & therapeutics - 50(2019), 7 vom: 01. Okt., Seite 823-824 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Korzenik, Joshua [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 30.03.2020 Date Revised 30.03.2020 published: Print CommentOn: Aliment Pharmacol Ther. 2019 Aug;50(3):289-294. - PMID 31267570 Citation Status MEDLINE |
|---|
| doi: |
10.1111/apt.15459 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM30140786X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30140786X | ||
| 003 | DE-627 | ||
| 005 | 20231225104548.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/apt.15459 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1004.xml |
| 035 | |a (DE-627)NLM30140786X | ||
| 035 | |a (NLM)31532552 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Korzenik, Joshua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Editorial |b anti-TNF therapy-a double-edged sword? Authors' reply |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.03.2020 | ||
| 500 | |a Date Revised 30.03.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Aliment Pharmacol Ther. 2019 Aug;50(3):289-294. - PMID 31267570 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
| 650 | 7 | |a Etanercept |2 NLM | |
| 650 | 7 | |a OP401G7OJC |2 NLM | |
| 700 | 1 | |a Larsen, Michael Due |e verfasserin |4 aut | |
| 700 | 1 | |a Nielsen, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Kjeldsen, Jens |e verfasserin |4 aut | |
| 700 | 1 | |a Nørgård, Bente Mertz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Alimentary pharmacology & therapeutics |d 1992 |g 50(2019), 7 vom: 01. Okt., Seite 823-824 |w (DE-627)NLM012692506 |x 1365-2036 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2019 |g number:7 |g day:01 |g month:10 |g pages:823-824 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/apt.15459 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2019 |e 7 |b 01 |c 10 |h 823-824 | ||